Biogen Inc.
Jane Grogan (Head of Research) reports BIIB insider transactions
AI-generated summary
Jane Grogan, Head of Research at Biogen Inc., had 695 shares from RSU vesting. They also disposed of 345 shares for tax withholding at an average price of $253.62, valued at $87,498.90. After these transactions, they directly held 4,408 shares of Common Stock.
Key facts
- Insider
- Jane Grogan · Head of Research
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | M · exercise or conversion of a derivative | +695 | $0.00 | $0.00 | 4,753 | Direct |
| Oct 30, 2026 | F · tax withholding | −345 | $253.62 | $87,498.90 | 4,408 | Direct |
| Oct 30, 2026 | M · exercise or conversion of a derivativeRestricted Stock UnitFootnotes F1 | −695 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of November 1, 2023.
Remarks: Power of Attorney is attached hereto as Exhibit 24.
More BIIB filings
- 10-Q
Filed Oct 28, 2026
- 8-K
Filed Oct 28, 2026
- 4
Filed Oct 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.